March 24, 2025 - 10:28

Asian shares experienced a downward trend on Monday, following a significant rebound in technology stocks that helped Wall Street break a four-week losing streak. Investors in the region are closely monitoring the implications of U.S. trade policies, particularly those initiated by President Donald Trump.
U.S. stock futures showed signs of improvement as market participants awaited further clarity on the administration's tariff strategies. Recent reports indicated that President Trump might refine his approach, potentially concentrating on countries that maintain substantial trade surpluses with the United States, many of which are located in Asia.
The looming deadline of April 2 for the implementation of additional tariffs on trading partners adds to the uncertainty. As traders digest these developments, the potential impact on global trade dynamics and market stability remains a focal point for investors in the Asian markets. The overall sentiment reflects caution as the region navigates the complex landscape of international trade relations.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...